Hydrogenology
Hydrogenology editorial study record

Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19

Shogenova LV, Truong TT, Kryukova NO, et al. · Cardiovascular Therapy and Prevention. 2021;20(6):2986.

HumanInhaled H₂Published 2021
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized controlled parallel prospective study

Research topic

Long COVID

Administration classification

Inhaled H₂

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Healthcare workers recovering from COVID-19 with post-COVID symptoms.

Sample

60 randomized: hydrogen plus standard rehabilitation n=30 and standard rehabilitation n=30; 27 and 28 completed, respectively.

Duration

90 minutes daily for 10 days.

Intervention

Hydrogen delivered by nasal cannula from a SUISONIA device for 90 minutes daily for 10 days, alongside standard rehabilitation.

Hydrogen form

The article calls the intervention an 'active form of hydrogen' from a metal-hydride source; it is not described as Brown's gas.

H₂ specification

The full article does not report source-gas H₂ concentration or purity.

H₂ flow

Not reported in the full article.

O₂ delivered with H₂

No O₂ concentration or O₂ flow is reported; no co-delivery is inferred.

Comparator

Standard rehabilitation including physiotherapy and supportive medication.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Endothelial indices, 6-minute walking distance, blood gases, lactate, inflammatory markers and adverse effects.

Reported result

The hydrogen group showed within-group changes in several measures, including 6-minute walk distance from 429±45 to 569±60 m. The article reports no procedure-related adverse effects; interpretation is limited by attrition and incomplete between-group reporting.

Results-extraction completeness

The free bilingual publisher full article, methods, tables, results and adverse-event statement were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small, apparently unblinded rehabilitation study with five dropouts and many endpoints. Several reported changes are within-group rather than clearly demonstrated treatment-versus-control effects. Gas concentration and flow are absent, and the article's unusual 'active hydrogen' chemical description should not be treated as established chemistry.

Applies directly to

Healthcare workers in post-COVID rehabilitation under the reported protocol.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

OpenAlex ID: W3205504592 · DOI: 10.15829/1728-8800-2021-2986

Publisher access

Open-access publisher article.

Extraction basis

Cardiovascular Therapy and Prevention full article; full-text extraction checked 8 August 2026.

Record revision

2026-08-10